In the present cohort, all patients carrying mutations in the TARDBP gene presented with a pure MND phenotype, as no patient fulfilled established clinical criteria for a defined FTD syndrome (61, 62). This evidence concerns the gene TARDBP and mild neurocognitive disorder.